We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
-15.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
-$79.4M
Cap. Flow
-$91M
Cap. Flow %
-43.93%
Top 10 Hldgs %
21.97%
Holding
890
New
197
Increased
94
Reduced
202
Closed
375

Top Buys

Rank Stock Value
1
DMLP icon
Dorchester Minerals
DMLP
+$5.04M
2
AMBA icon
Ambarella
AMBA
+$3.51M
3
TCRT icon
Alaunos Therapeutics
TCRT
+$3.39M
4
CELG
Celgene Corp
CELG
+$3.33M
5
SONC
Sonic Corp
SONC
+$3.31M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.89M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$6.46M
3
AAPL icon
Apple
AAPL
+$5.32M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.25M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 17.98%
2 Technology 16.3%
3 Consumer Discretionary 16.11%
4 Consumer Staples 11.7%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OIH icon
326
VanEck Oil Services ETF
OIH
$1.97B
$22K 0.01%
33
-1,695
-98% -$1.16M
ENDP
327
DELISTED
Endo International plc
ENDP
$22K 0.01%
+240
New +$20.1K
APTV icon
328
Aptiv
APTV
$9.43B
$21K 0.01%
268
-1,345
-83% -$101K
BWA icon
329
BorgWarner
BWA
$13.2B
$21K 0.01%
+387
New +$19.7K
CFR icon
330
Cullen/Frost Bankers
CFR
$10B
$21K 0.01%
300
-579
-66% -$38.9K
CMA
331
DELISTED
Comerica
CMA
$21K 0.01%
464
-2,162
-82% -$96.5K
IBB icon
332
iShares Biotechnology ETF
IBB
$10.8B
$21K 0.01%
180
-1,488
-89% -$164K
TT icon
333
Trane Technologies
TT
$100B
$21K 0.01%
+305
New +$20.1K
DD
334
DELISTED
Du Pont De Nemours E I
DD
$21K 0.01%
316
-4,034
-93% -$288K
HSP
335
DELISTED
HOSPIRA INC
HSP
$21K 0.01%
+244
New +$19.1K
RGP
336
DELISTED
REGENCY ENERGY PARTNERS LP COMMON UTS REP LIMITED PART INTS
RGP
$21K 0.01%
+900
New +$21.2K
CEO
337
DELISTED
CNOOC Limited
CEO
$21K 0.01%
+150
New +$20.7K
IYE icon
338
iShares US Energy ETF
IYE
$1.82B
$20K 0.01%
+450
New +$19.7K
SPG icon
339
Simon Property Group
SPG
$69.5B
$20K 0.01%
100
-1,000
-91% -$194K
TM icon
340
Toyota
TM
$227B
$20K 0.01%
+145
New +$19.4K
CTRX
341
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$20K 0.01%
+329
New +$16.7K
UN
342
DELISTED
Unilever NV New York Registry Shares
UN
$20K 0.01%
475
-22,285
-98% -$935K
EWL icon
343
iShares MSCI Switzerland ETF
EWL
$2.42B
$19K 0.01%
+561
New +$18.3K
EXP icon
344
Eagle Materials
EXP
$6.06B
$19K 0.01%
+227
New +$17.7K
FCX icon
345
Freeport-McMoran
FCX
$113B
$19K 0.01%
1,000
-49,787
-98% -$985K
SON icon
346
Sonoco
SON
$5.61B
$19K 0.01%
+418
New +$18.9K
TV icon
347
Televisa
TV
$1.45B
$19K 0.01%
+575
New +$19.3K
VOD icon
348
Vodafone
VOD
$36.7B
$19K 0.01%
581
-5,815
-91% -$200K
DLS icon
349
WisdomTree International SmallCap Dividend Fund
DLS
$1.09B
$18K 0.01%
+296
New +$17.1K
RAD
350
DELISTED
Rite Aid Corporation
RAD
$18K 0.01%
102
-644
-86% -$100K
12 13
14
15 16

Similar funds

ACM
Axel Capital Management New York $47.4M AUM 2.75% 1-Year Est. Return
SJIA
St. James Investment Advisors Port Jefferson, New York $54.6M AUM 0.39% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
DFAM
Deep Field Asset Management Beverly Hills, California $57.7M AUM 29.92% 1-Year Est. Return
AI
Abanco Investors Middletown, Rhode Island $57.9M AUM
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
JI
Jeereddi Investments Los Angeles, California $38.1M AUM 12.15% 1-Year Est. Return

Crosspoint Capital Strategies's Q1 2015 Portfolio in Review

As of Q1 2015, Crosspoint Capital Strategies held 890 positions worth $207M, down 28% from $287M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Crosspoint Capital Strategies withdrew a net $91M in Q1 2015, closing 375 positions and reducing 202 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Crosspoint Capital Strategies opened a new position in Dorchester Minerals worth $4.64M.

  • Crosspoint Capital Strategies's largest Q1 2015 buy was Dorchester Minerals: 204,210 shares worth $4.64M.
  • Crosspoint Capital Strategies added most to Ambarella in Q1 2015, an estimated $3.51M increase.
  • Crosspoint Capital Strategies's biggest Q1 2015 reduction was Berkshire Hathaway Class B, cutting an estimated $7.89M.
  • Crosspoint Capital Strategies fully exited Agios Pharmaceuticals in Q1 2015, selling an estimated $4.46M.
  • Crosspoint Capital Strategies's ten largest holdings make up 22% of its $207M portfolio in Q1 2015.
  • Crosspoint Capital Strategies opened 197 new positions and closed 375 in Q1 2015.
  • Crosspoint Capital Strategies's portfolio value fell 28% quarter-over-quarter to $207M.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2015, filed 18 May 2015.